Type 1 diabetes mellitus with stable proliferative diabetic retinopathy (bilateral)
ICD-10 E10.3553 is a billable code used to indicate a diagnosis of type 1 diabetes mellitus with stable proliferative diabetic retinopathy (bilateral).
E10.3553 refers to Type 1 diabetes mellitus characterized by the presence of stable proliferative diabetic retinopathy in both eyes. Proliferative diabetic retinopathy (PDR) is a severe form of diabetic eye disease that occurs when new, abnormal blood vessels grow on the retina, which can lead to vision loss. In patients with Type 1 diabetes, the onset of diabetic retinopathy is often linked to the duration of diabetes and poor glycemic control. The term 'stable' indicates that the condition has not progressed or worsened, which is crucial for management and treatment planning. Regular monitoring of HbA1c levels is essential, as maintaining these levels below 7% can help prevent the progression of diabetic complications, including retinopathy. Insulin management is critical in Type 1 diabetes, as patients require exogenous insulin to maintain blood glucose levels. The presence of bilateral PDR necessitates close collaboration between endocrinologists and ophthalmologists to ensure comprehensive care and timely interventions to preserve vision.
Detailed records of diabetes management, including insulin regimens and HbA1c levels.
Patients presenting with uncontrolled blood sugar levels and complications.
Ensure that all diabetes-related complications are documented and linked to the primary diagnosis.
Comprehensive eye examination reports, including findings related to diabetic retinopathy.
Routine eye exams for diabetic patients and management of retinopathy.
Document the stability of retinopathy and any interventions performed.
Used during routine eye exams for diabetic patients.
Document findings related to diabetic retinopathy and visual acuity.
Ophthalmologists should ensure thorough documentation of retinopathy status.
Stable diabetic retinopathy indicates that the condition has not progressed or worsened over time, which is crucial for treatment planning and monitoring.
